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Abstract
Acute gastroenteritis is a main cause of disease and death among children in low-income countries. The causality rates and pathogenic
characteristics of putative aetiological agents remain insufficiently known. We used real-time PCR targeting 16 diarrhoeagenic agents to
analyse stool samples from children ≤5.0 years old with acute diarrhoea in Rwanda. Among the 880 children (median age 14.2 months; 41%
female) at least one pathogen was detected in 92% and two or more agents in 63% of cases. Rotavirus was detected in 36.9%, adenovirus in
39.7%, enterotoxigenic Escherichia coli (ETEC) with genes for labile (eltB) or stable (estA) toxin in 31.3% and 19.0%, E. coli with eae or bfpA
genes in 25.2% and 14.2%, Shigella in 17.5% and Cryptosporidium in 7.8%. Rotavirus and ETEC-estA were associated with more severe
dehydration than diarrhoea due to other causes. Shigella was associated with bloody stools and higher CRP. Microbial loads (Ct values) of
rotavirus, ETEC-estA and Shigella were associated with severity of symptoms. Rotavirus, ETEC-estA and E. coli with bfpA were associated with
younger age, Shigella with older age. Antibiotic treatment was given to 42% and was associated with dehydration, fever and CRP, but not
with pathogen. We conclude that rotavirus and ETEC-estA were the most important causes of diarrhoea with dehydration, that Shigella
caused bloody diarrhoea but less severe dehydration, that microbial loads of rotavirus, ETEC-estA and Shigella were associated with severity
of symptoms, and that antibiotic use was frequent and in poor agreement with microbiological findings.
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Background
Acute diarrhoeal disease is the second most common cause of
death world-wide in children under 5 years of age [1]. Most of
the morbidity occurs in low-income countries, where the
aetiologies and epidemiology of gastroenteritis remain incom-
pletely understood. A recent global multicentre study pro-
vided strong evidence that rotavirus, enterotoxigenic
Escherichia coli (ETEC), Cryptosporidium and Shigella are the
main causative agents [2], but it is important to obtain more
information about the relative importance of different aetiol-
ogies and their clinical characteristics. Improvements of
hygiene, sanitary standards, food handling, nutrition status
and healthcare are general goals for low-income countries that
may reduce the burden of diarrhoeal disease. However,
decisions regarding more specific interventions such as
vaccination against rotavirus [3], Shigella or ETEC [4] and use
of antibiotics [5] are important and require data from studies
that investigate the majority of putative aetiologies, preferably
using methods with a similar diagnostic performance for all
causative agents. New multi-targeting molecular methods
should be useful for such investigations because they allow
detection of essentially all diarrhoeagenic pathogens with high
specificity and sensitivity [6–8].
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Identification of causative agents is typically based on
comparison between patients and controls. In the present
study, we instead investigated pathogenicity by relating severity
of symptoms to, firstly, the mere detection of essentially all
putative diarrhoeagenic agents, and secondly, to pathogen
load. By these approaches we found that rotavirus, ETEC
carrying a gene for heat stable enterotoxin and Shigella were
the main pathogens, and observed novel associations between
pathogen load and symptoms.
Methods
Patients and samples
We included in this study children seeking care at any of three
health centres, two district hospitals or one university teaching
hospital in Kigali, or any of two health centres, one district
hospital or one university teaching hospital in Butare, Rwanda,
during repeated study periods from November 2009 to June
2012, so as to cover both rainy and dry seasons. The inclusion
criteria were age ≤5.0 years and diarrhoea with duration of
<96 h (with or without vomiting or fever), and exclusion
criteria were non-enteric acute infections, severe malnutrition
and AIDS. The specimen type was faeces only in 535 cases,
rectal swab only in 159 cases and both faeces and rectal swab
in 184 cases. In the latter 184 cases, the lowest Ct (threshold
cycle) value (or the only Ct value if only one was PCR positive)
was recorded.
Clinical characteristics
The following clinical parameters were registered: body
temperature (axillary); history of vomiting, stool frequency
and blood in faeces (according to parent/carer); degree of
dehydration; type of rehydration (oral or intravenous) or
antibiotic treatment (for patients who were sent home as well
as for those who stayed in hospital). Dehydration was scored
by the study nurse on arrival according to WHO guidelines as
severe (reduced consciousness, lack of urine output, cool,
moist extremities, rapid and feeble pulse, low or undetectable
blood pressure, pale skin), moderate (thirst, restlessness,
irritable behaviour, decreased skin elasticity, sunken eyes),
mild or none (absence of these symptoms). For patients who
remained at a district or university hospital the duration of
hospitalization and survival were recorded; no follow-up was
performed for patients who were sent home (their outcome
was recorded as survival).
Stool sample collection
Stool samples were collected as a rectal swab (Copan Regular
Flocked Swab 502CS01, Copan Italia Spa, Brescia, Italy) in a
tube with 1 mL of sterile saline, or as 2 mL of faeces [9]. The
samples were sent to a local laboratory for storage at 80°C
until transport to the Department of Infectious Diseases at
University of Gothenburg, Sweden, where molecular testing
was performed.
Microbial agents and target sequences
The targets for real-time PCR are described in Table S1.
Amplified regions of viruses were located to conserved
genomic regions, using established primers and probes [10–
13]. Samples reactive for adenovirus were tested by an
additional PCR targeting only types 40/41. Assays for bacteria
and protozoa were developed by adapting traditional PCR to
real-time PCR [14–23]. For ETEC, both heat labile toxin (eltB)
and heat stable toxin (estA) genes were targeted [22,23], as
were genes coding for intimin (eae) and bundle-forming pilus
(bfpA), considered to be markers for enteropathogenic E. coli
(EPEC) [20,21]. Shigella was identified by amplification of the
invasion plasmid antigen H gene (ipaH, which also may be
present in enteroinvasive E. coli (EIEC). The target gene was
fibronectin-binding protein for Campylobacter, enterotoxin Yst
precursor for Yersinia enterocolitica, cholera toxin A subunit for
Vibrio cholerae, outer membrane protein C for Salmonella, and
oocyst wall protein for Cryptosporidium.
Sample preparation and nucleic acid extraction
Approximately 250 lL of faeces were dissolved in 4.5 mL of
saline and centrifuged for 5 min at 750 g. Then, 250 lL of
dissolved faeces or 250 lL of rectal swab fluid were mixed with
2 mL of lysis buffer, and this volume was used for extraction of
total nucleic acid in an EasyMag instrument (Biomerieux, Marcy
l’Etoile, France). The nucleic acids were eluted in 110lL and
5 lL of this were used for real-time PCR. These procedures
correspond to an approximate dilution of faeces to 1:10 prior
to PCR. The dilution of rectal swab samples depends on the
specimen volume contained in the swab, but typically was 1:10
to 1:100 [9]. These dilutions effectively prevent the potential
impact of factors that might inhibit amplification [9].
Real-time PCR
Amplificationwas performed in anABI7900 instrument (Applied
Biosystems, Foster City, CA, USA) in 11 parallel 20-lL reactions
containing oligonucleotides (Table S1) and Taqman Fast Virus
1-step Mastermix (ABI, for RNA targets) or Universal Master-
mix (ABI, for DNA targets). A two-step amplification (15 s
95°C, 60 s 56°C) was run for 45 cycles after an initial 10 min
denaturation at 95°C and 30 min reverse transcription at 46°C.
Plasmids (pUC57) containing the target regions for all agents
were amplified in parallel with patient specimens to verify the
performance of each target PCR (mastermix control).
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The result from PCR was recorded as detected or not (a
qualitative result) and as the Ct (threshold cycle) value, a
quantitative parameter that has a negative linear relationship to
the logarithm of the concentrations of the pathogen in faeces.
C-reactive protein
CRP levels in blood samples drawn on admission were
measured at a local laboratory in Rwanda by the NycoCard
assay (Medinor, Liding€o, Sweden) according to the manufac-
turer’s instructions. Briefly, 5 lL of capillary blood were
diluted and 50 lL of diluted samples were added to a reaction
device, followed by the addition of one drop of conjugate and
after 30 s one drop of washing solution, and measurement in
NycoCard Reader II.
Ethical committee approval
The study was approved by the regional ethical review board
in Gothenburg and by the ethical committee at the National
University of Rwanda. An informed consent was obtained from
the parents/carers of each child included in the study.
Statistics
Fisher’s exact test was used for analysing associations between
pathogen detection (yes/no) and symptoms. Threshold cycle
(Ct) values were compared by logistic regression, age with
t-test in univariate analysis. Multiple logistic regression analysis
was performed with vomiting, degree of dehydration or
intravenous fluid therapy as dependent variables, and age
(continuous) in combination with PCR reactivity (yes/no) or Ct
values (continuous) as independent variables. The JMP soft-
ware (SAS Institute Inc., Cary, NC, USA) was used for
statistical analyses.
Results
General
Patient characteristics of the 880 patients are shown in
Table 1. The majority (72%) had a history of vomiting, 13% had
signs of severe dehydration and 34% no or mild dehydration.
Nearly all patients (97%) received oral rehydration solution,
almost half receiving intravenous fluids, and 42% received
antibiotics.
Detection frequencies
At least one pathogen was detected in 92% of the cases. As
shown in Table 2, the most frequent agents were adenovirus
(39.7%), rotavirus (36.9%), ETEC-eltB (31.3%) and EPEC eae
(25.2%). In most cases, these agents were found together with
other pathogens, and infection with two or more agents was
seen in 63% (n = 558) of all cases (Fig. 1a). Among infections
with only one agent (n = 251), rotavirus was the most
common (37.1%), followed by adenovirus (14.3%), Shigella
(9.2%) and ETEC-eltB (8.8%). Rotavirus was detected at a
similar frequency among co-infected patients; other agents
were more often present as co-infections (Fig. 1b). Only 16.2%
(35/216) of the cases with adenovirus were identified as types
40 or 41. Escherichia coli with the EPEC markers eae and bfpA
were detected at different rates (25.2% and 14.2%), as was also
seen for ETEC (31.3% with eltB and 19.0% with estA genes).
Detection frequencies and clinical parameters
The frequency of symptoms in cases positive or negative for
each pathogen is shown in Table 2. For rotavirus, ETEC-estA
and Shigella associations with vomiting, dehydration, intrave-
nous fluid treatment and CRP remained when age was
included in the analysis, as shown in Table 3. Rotavirus and
ETEC-estA were also associated with more frequent diarrhoea
(mean 6.06 vs. 5.74 stools/day, p 0.005, and 6.23 vs. 5.78
stools/day, p 0.052).
Shigella was associated with higher CRP levels (p 0.0005)
and presence of blood in faeces (p 0.015), but of the 154
patients with Shigella, only 13 (8.4%) had bloody diarrhoea
(OR = 2.47, p 0.015), and 32 (21%) had CRP > 50 mg/L
(OR = 1.3). Cryptosporidium (OR = 1.68, p 0.044), Campylo-
bacter (OR = 1.49, p 0.030) and EPEC-bfpA (OR = 1.50, p
0.041) were associated with intravenous fluid therapy.
Pathogen load (Ct values) and symptoms
In order to study the potential association between disease
and concentration of pathogen in faeces, Ct values were related
TABLE 1. Clinical information for 880 children with
diarrhoea
Age and gender
Months of age, median (IQR) 14.2 (9.1–23.8)
Age <12/12–24/>24 months 350/312/218 (40%/35%/25%)
Female/male 362/518 (41%/59%)
Clinical presentation
Duration of symptoms, mean (SD) 2.4 (0.80) days
Vomiting: yes/no 630/249 (72%/28%)
Frequency of diarrhoea, >6/<6 per day 288/592 (33%/67%)
Temperature, ≥38.0/<38.0°C 402/475 (46%/54%)
Dehydration: severe/moderate/no or mild 110/470/300 (13%/53%/34%)
CRP, >50/10–50/<10 mg/L 137/248/388 (18%/32%/50%)
Clinical care
Level of care: health centre/district
hospital/university hospital
419/421/40 (48%/48%/4%)
Clinical decision: hospitalized/referred/
sent home
388/59/433 (44%/7%/49%)
Mean duration (SD) in hospital for
patients not sent home
2.87 (1.50) days
ORS therapy: yes/no 851/28 (97%/3%)
Intravenous rehydration: yes/no 405/473 (46%/54%)
Zinc treatment: yes/no 695/185 (79%/21%)
Antibiotic treatment: yes/no 373/506 (42%/58%)
Outcome: recovered/died 875/5 (99.4%/0.6%)
IQR, interquatile range (25–75%); ORS, oral rehydration solution.
Total number was <880 for some variables due to missing data.
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to clinical parameters. As shown in Table 3, higher viral load
(lower Ct) of rotavirus was associated with vomiting, more
severe dehydration and intravenous fluid therapy. Similarly, a
higher concentration of ETEC-estA was associated with
vomiting and intravenous fluid therapy, and higher load of
Shigella was associated with dehydration and intravenous fluid
therapy.
Importance of age
As shown in Fig. 2, rotavirus, ETEC-estA and EPEC-bfpA were
more frequent (p <0.005) in younger patients (observed in
50%, 23% and 21% of children <12 months, as compared with
18%, 12% and 7.3% of those >24 months of age). Conversely,
Shigella was more common (p 0.0005) in older children (24% in
children >24 months, 5.1% in those <12 months of age).
Younger age was associated with severe dehydration,
hospitalization and intravenous fluid therapy irrespective of
infecting agent (p 0.0001), and to some extent the associations
between pathogen detection or concentration and clinical
parameters mentioned above were related to age. However,
significant associations between detection of rotavirus or
ETEC-estA and more severe dehydration or need for intrave-
nous fluids, were observed also when age was taken into
account (Table 3, upper part). The significant associations
between clinical markers (vomiting, dehydration and intrave-
nous fluid therapy) and pathogen load of rotavirus, ETEC-estA
and Shigella also remained when age was taken into account
(Table 3, lower part).
CRP and pathogen detection
The only agent associated with higher CRP levels was Shigella
(p 0.002), as shown in Table 1. CRP was associated with blood
in faeces (p 0.031), blood or mucus in faeces (p 0.0008) and
higher body temperature (p 0.0059).
Prescription of antibiotics
Antibiotics were given to 373 patients (42%). Cotrimoxazol
was used in 37%, amoxicillin or ampicillin in 25%, ampicillin and
gentamycin in 20%, cefotaxim in 12%, ciprofloxacin in 2% and
erythromycin in 2% of these cases.
There was no significant association between any pathogen
and antibiotic treatment. Among cases with only one detected
pathogen (n = 251), antibiotics were given to 45.8% of
non-bacterial and to 42.1% of bacterial cases. Neither age
nor presence of blood in faeces influenced the use of
antibiotics. However, antibiotics were more often given to
children with body temperature above 38°C (p <0.0001) or
with elevated CRP levels (59%, 43% or 39% if CRP was ≥50,
10–50 or <10 mg/L; p 0.0059), or if dehydration was significant
(58%, 44% or 35% if dehydration was severe, moderate or
mild/none; p 0.0001).
Discussion
The present study demonstrates the utility of a broad
real-time PCR panel for investigating causes of acute gastro-
enteritis in children in a low-income country. Using this
technique, at least one diarrhoeagenic agent was detected in
92% of 880 children with diarrhoea for <96 h, and two or
more agents were detected in 63%. A control group of healthy
children was not included in this study, so we could not assess
the burden of disease attributed to each pathogen. However,
by relating detection frequencies and pathogen load estimates
(Ct values) to clinical parameters several associations were
identified.
Firstly, detection of rotavirus or ETEC-estA was associated
with higher rate of vomiting, more frequent diarrhoea, more
severe dehydration and more need for intravenous fluid
(a)
(b)
FIG. 1. (a) Number of microbial agents detected by PCR in faeces
from 880 children with diarrhoea. (b). Detection frequency for each
agent among 251 patients with mono-infection and 558 patients with
co-infections (≥2 detected agents).
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therapy than when not detected (i.e. when diarrhoea had
another cause). These results indicate that these two agents
are not only the most frequent causes of diarrhoea in
low-income countries, along with Cryptosporidium and Shigella
[2], but also more likely than other agents to cause severe
dehydration. The finding that ETEC-estA was more patho-
genic than ETEC-eltB agrees with previous studies [2,24,25],
and points to the need for an ETEC-estA vaccine. The
pathogenicity of Cryptosporidium could not be well addressed
because the detection frequency was relatively low. Shigella
was the only agent associated with enhanced CRP levels or
bloody faeces, although the latter was seen in only 8.4% of
the Shigella cases. A limitation of our study is the lack of
Shigella species identification, and that identification by the
ipaH gene does not distinguish Shigella and enteroinvasive
E. coli. Still, the results support the observations in previous
studies that Shigella is an important cause of childhood
diarrhoea [26,27]. The lower degree of dehydration as
compared with rotavirus and ETEC-estA might have a bearing
on recommendations for the use antibiotics, and calls for
further studies.
By relating real-time PCR Ct values to markers for disease,
we investigated whether microbial concentrations in faeces
were linked to disease. We found that lower Ct values
(higher microbial concentrations) for rotavirus were associ-
ated with more vomiting, more severe dehydration and
intravenous fluid therapy. Likewise, lower Ct values of
ETEC-estA were associated with vomiting and intravenous
fluid therapy, and lower Ct values of Shigella were associated
with more severe dehydration and intravenous fluid therapy.
Previous studies have reported that quantification of rotavi-
rus [28], ETEC-estA [29], norovirus GII [29], Cryptosporidium
[29] or Shigella [29,30] may serve to distinguish symptomatic
and asymptomatic infections, but to our knowledge this is the
first study that associates faecal pathogen load estimates (Ct
values) of rotavirus, ETEC-estA and Shigella with severity of
symptoms.
Age was associated with clinical symptoms and also closely
related to detection frequencies for rotavirus, ETEC-estA,
EPEC-bfpA and Shigella, with 50% and 18%, 23% and 12%, 21%
and 7.3%, and 5% and 24% of cases below 12 and above
24 months of age, in agreement with previous reports [2].
FIG. 2. Detection frequencies among 880 children with diarrhoea by age group. ** p <0.01, *** p <0.001, by t-test comparing age as continuous
variable.
TABLE 3. Upper part shows multiple logistic regression analysis including age and detection (yes or no) of rotavirus, ETEC-estA
and Shigella as independent variables, and vomiting, dehydration or intravenous fluid treatment as dependent variables. Lower
part shows age-adjusted associations between Ct value and vomiting, dehydration or intravenous fluid therapy
Vomiting
yes/no
Severe dehydration
yes/no
Intravenous fluid
yes/no
OR (CI) p value OR (CI) p value OR (CI) p value
Rotavirus 2.28 (1.60–3.29) <0.0001 1.91 (1.25–2.94) 0.0031 2.79 (2.05–3.80) <0.0001
ETEC-estA 1.13 (0.76–1.72) 0.54 1.79 (1.13–2.82) 0.012 1.42 (0.99–2.05) 0.060
Shigella 0.94 (0.64–1.40) 0.78 0.78 (0.39–1.45) 0.45 0.73 (0.48–1.08) 0.12
Age 1.36 (1.19–1.56) <0.0001 1.48 (1.16–1.92) 0.0025 1.67 (1.43–1.95) <0.0001
Rotavirus Ct n = 325 1.57 (1.04–2.33) 0.032 1.47 (0.94–2.44) 0.09 2.18 (1.54–3.11) <0.0001
Campylobacter Ct n = 147 2.21 (1.09–4.63) 0.03 1.90 (0.82–4.66) 0.13 1.64 (0.90–3.02) 0.11
ETEC-estA Ct n = 167 1.74 (1.08–2.84) 0.024 0.97 (0.59–1.60) 0.89 1.81 (1.20–2.75) 0.004
Shigella Ct n = 154 1.10 (0.61–1.99) 0.75 3.89 (1.23–15.0) 0.02 2.29 (1.21–4.55) 0.01
OR, odds ratio.
OR in upper part compares positive vs. negative by PCR, and ratio per 1 year decrease for age. OR in lower part shows ratio per 10 cycles of Ct value decline ( per 3 log10
increase in pathogen concentration).
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Thus, differences in age were present for the same agents
that were associated with disease markers, indicating that the
latter might be attributed to age rather than to microbial
pathogenicity. To some extent this was true, because
younger age was strongly associated with dehydration and
need for hospitalization. However, in multiple logistic
regression analysis including age, the associations between
disease and detection or Ct values of rotavirus and ETEC-estA
remained.
Salmonella was detected in 6.6%, but with high Ct values,
using a target gene (ompC) presumed to be present in all
Salmonella types. Complementary testing of 36 samples
using a real-time PCR targeting the InvA gene (considered
to be specific for enteritic types) was reactive in only four
cases (not shown). The significance of the Salmonella
ompC gene detection in the other cases is uncertain, but
might be due to low levels of non-enteritic Salmonella,
possibly reflecting exposure from animals in the environ-
ment.
Antibiotics were given to 42% of all children. They were
more often given to children with fever, elevated CRP or
severe dehydration, but not more often if blood was present in
faeces, and were as commonly prescribed for viral as bacterial
infections. These findings argue against the use of antibiotics
for acute diarrhoea in children, because most treated patients
had viral infections and many patients with Shigella or other
bacterial infections that might benefit from treatment were not
treated. Also, the value of treatment is uncertain even if
diarrhoea has bacterial aetiology, in particular as antibiotic
resistance is frequent and increasing. The milder degree of
dehydration in patients with Shigella also may argue against the
use of antibiotics, which, however, might be justified in
children with bloody diarrhoea.
In summary, a broad real-time PCR panel was useful for
studying microbial agents in faeces from children with
diarrhoea, revealing at least one pathogen in 92% of cases.
Rotavirus and ETEC-estA were the most important aetiologies,
and for these agents, as well as for Shigella, clinical symptoms
were associated with microbial load.
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